Cure8

Why This Matters

People with IBD are at higher risk for shingles largely because of immunosuppressive treatments; an effective vaccine (RZV) is recommended by major societies but is underused in some places.

Who Should Pay Attention

Adults with IBD (including Crohn's), patients on immunosuppressants or JAK inhibitors, gastroenterologists, primary care clinicians, and public-health planners.

Study Snapshot

Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract

What To Know

This review summarizes evidence that people with IBD face an increased risk of herpes zoster — especially those on JAK inhibitors, combination immunosuppression, or high-dose steroids — and that RZV offers substantial protection (reported efficacy ~65%-90%) and reduces postherpetic neuralgia without increasing IBD flares.

Major guideline bodies (ACG, ECCO, ACIP) recommend RZV for IBD patients ≥50 years and for adults ≥19 years receiving immunosuppressive therapy. Real-world data support benefits across ages and treatment types, but implementation gaps exist in resource-limited settings; the authors suggest prioritising higher-risk patients when resources are constrained.

Keep In Mind

Based on the article abstract (review). Recommendations cited are from guideline bodies; this is not new randomized-trial data. Availability and cost vary by region and may limit implementation.

Source Details

Review the original publication for the complete reporting, methods, and context.

Read Original Source
Research paper Evidence type derived from source or registry metadata.
PublicationWorld journal of virology
AuthorsManish Manrai, Aditya V Pachisia, Atul A Jha +3 more
InstitutionDepartment of Gastroenterology, Command Hospital, Lucknow 226002, Uttar Pradesh, India. manishmanrai75@gmail.com.
Study typeJournal article, review
Indexed viaPubMed
Source typeResearch paper
PublishedSep 25, 2026, 12:00 AM
Content availableJournal abstract

Conflict statement: Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.

Related Reading

Browse latest news →